Ci-joint ce qui est toujours à ce jour la meilleure revue récente sur la prise de poids sous psychotropes. Le résumé Medline est inclus dans ce message.
Dr Philippe Cialdella
Dr Philippe Cialdella
Zimmermann U, Kraus T, Himmerich H, Schuld A, Pollmächer T.
J Psychiatr Res. 2003 May-Jun;37(3):193-220.
Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients. Max Planck Institute of Psychiatry, Kraepelinstr. 10, 80804, Munich, Germany.zimm@mpipsykl.mpg.de
This paper reviews the available epidemiological data on the frequency and extent of weight gain associated with antidepressant, mood-stabilizing, and antipsychotic treatment. Possible underlying pathomechanisms are discussed with special attention to central nervous control of appetite including the role of leptin and the tumor necrosis factor system. Metabolic alterations induced by drug treatment such as type 2 diabetes mellitus and the metabolic syndrome are also considered. Weight gain appears to be most prominent in patients treated with some of the second generation antipsychotic drugs and with some mood stabilizers. Marked weight gain also frequently occurs during treatment with most tricyclic antidepressants, while conventional antipsychotics typically induce only slight to moderate weight gain. Serotonin reuptake inhibitors may induce weight loss during the first few weeks, but some of them induce weight gain during long-term treatment. Several antidepressant and antipsychotic drugs are identified which reliably do not cause weight gain or even reduce weight. Based on these insights, countermeasures to manage drug-induced weight gain are suggested.
0 commentaires:
Enregistrer un commentaire